Foreign direct investment and global value chains in the wake of COVID-19: Lead firms of GVC
Gilead, Galapagos claim PhIIb/III win for filgotinib in ulcerative colitis — which pales in comparison to rivals
Macro Briefing | 21 May 2020
Chart of the WeekTracking the $9 Trillion Global Fiscal Support to Fight COVID-19
Fed Funds Futures No Longer Imply Negative Rates
China Leaves Rates Unchanged. Japan Machinery Orders Rebound
Partial measures compromise effectiveness of efforts to combat COVID-19
SoftBank Loses Alibaba’s Jack Ma and Posts Worst Losses in History
Covid-19 roundup: Kate Bingham to lead UK taskforce; Federal judge to Shkreli: You’re not going to save the world, stay in prison
Macro Briefing | 18 May 2020
Yuan Slumps as US-Chinese Tensions Rise
Reopening Trump’s Trade: Gold Is On The Move
Will PMIs Show Economies Hit Bottom? Are US-China Tensions Rising Again?
What The Future Holds for Industries Most Affected By COVID-19
Week Ahead – More Easing on the Way
5 things to know about Chinese and emerging market stocks
Alexion’s Decision To Purchase Portola Sparks Activist Campaign
Nonlinear Thinking in a Linear Market
Navigating the Low-Rate Environment
Engagement in the Work-From-Home Era
Time To Build Without VCs
Has The Stock Market Gone Mad? Long Gambling Ideas
Covid-19 roundup: Gilead selects 5 generic manufacturing partners for remdesivir; CanSino outlines PhI/II study in Canada
Las Vegas Sands Puts A Lid On Potential Japanese Development
“Support”
Can Monopoly Money Save the Stock Market? Or Will It Buy Stagnation?
Empire State Realty Trust Poised To Bear The Full Brunt Of This Storm
Emerging from the Great Lockdown in Asia and Europe
2 Cruise Line Stocks to Bet on After the Coronavirus Crisis (And 1 to Avoid)
Negative interest rates are coming, investors taking action